Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol alone versus misoprostol plus vaginal estrogen for cervical preparation before labor induction
IRCT20250225064853N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol and DehydraTECH-estrogen in None (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Time to reach active labor phase, Mode of delivery and 2 more. Started Sep 2025; status: completed.
02
Drugs
misoprostolDehydraTECH-estrogen
Beyond the preview
Go deeper on IRCT20250225064853N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250225064853N4.